US Stock MarketDetailed Quotes

TXMD TherapeuticsMD

Watchlist

1.640
-0.010-0.61%

Close Sep 27 16:00 ET

1.640
0.0000.00%

Post 18:29 ET

18.91MMarket Cap-3037P/E (TTM)

TherapeuticsMD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

142.84%1.45M

97.37%-229K

-346.67%-23.1M

-116.47%-4.98M

-134.03%-6.03M

83.63%-3.39M

51.31%-8.7M

116.99%9.37M

-37.00%30.24M

146.35%17.72M

Net income from continuing operations

56.50%-1.05M

64.98%-809K

-816.85%-7.7M

-103.18%-1.54M

90.20%-1.43M

83.77%-2.41M

87.08%-2.31M

101.35%1.07M

-3.38%48.45M

69.15%-14.63M

Depreciation and amortization

39.53%180K

392.59%133K

-25.00%900K

94.62%615K

-52.75%129K

-54.26%129K

-91.79%27K

63.04%1.2M

113.42%316K

-73.50%273K

Other non cash items

1,155.56%190K

410.00%186K

73.32%-107K

-68.09%-632K

6,130.00%603K

-125.00%-18K

-757.14%-60K

-155.69%-401K

92.83%-376K

-100.43%-10K

Change In working capital

150.82%776K

102.17%150K

-326.97%-17.45M

83.64%-3.46M

-120.01%-5.56M

81.73%-1.53M

-189.92%-6.9M

-189.00%-4.09M

-3,367.70%-21.14M

1,849.02%27.79M

-Change in prepaid assets

-68.81%500K

102.34%34K

222.42%2M

1,333.63%3.24M

-114.79%-1.39M

115.93%1.6M

-238.12%-1.45M

155.11%620K

-86.75%226K

394.31%9.41M

-Change in payables and accrued expense

98.92%-40K

93.04%-301K

-684.99%-17.85M

68.11%-4.46M

-128.79%-5.37M

-301.53%-3.69M

-25.93%-4.32M

-14.71%3.05M

-65.61%-14M

233.50%18.65M

-Change in other current assets

30.64%631K

3,410.53%629K

85.25%-1.13M

69.74%-2.31M

--721K

--483K

---19K

---7.64M

--0

-Change in other current liabilities

-488.89%-315K

80.83%-212K

-289.26%-471K

-71.21%76K

283.85%478K

164.80%81K

---1.11M

-105.66%-121K

-80.88%264K

-165.00%-260K

Cash from discontinued investing activities

Operating cash flow

142.84%1.45M

97.37%-229K

-346.62%-23.08M

-116.40%-4.96M

-134.03%-6.03M

83.63%-3.39M

51.31%-8.7M

106.56%9.36M

176.43%30.24M

146.35%17.72M

Investing cash flow

Cash flow from continuing investing activities

84.03%-355K

95.11%-74K

103.85%7K

Net PPE purchase and sale

----

--0

Net intangibles purchase and sale

----

--0

----

83.78%-355K

93.73%-95K

102.78%7K

Cash from discontinued investing activities

Investing cash flow

----

--0

----

84.03%-355K

95.11%-74K

103.85%7K

Financing cash flow

Cash flow from continuing financing activities

101.34%3.15M

101.79%2M

-100.06%-1K

-281.55%-235.21M

-8,373.84%-111.95M

-94.54%1.74M

Net issuance payments of debt

----

--0

----

-338.86%-219.43M

---94.43M

--0

Net common stock issuance

----

27.67%3.15M

14,200.00%2M

-100.04%-1K

----

-98.66%2.47M

-98.95%14K

-92.32%2.45M

Net preferred stock issuance

----

--0

----

---16.97M

----

Net other financing activities

----

75.21%-1.27M

---540K

----

Cash from discontinued financing activities

Financing cash flow

----

101.34%3.15M

101.79%2M

-100.06%-1K

----

-281.55%-235.21M

-8,373.84%-111.95M

-94.54%1.74M

Net cash flow

Beginning cash position

-74.85%4.34M

-91.23%4.33M

-24.27%49.32M

-73.48%10.17M

-47.80%13.73M

-43.23%17.25M

-24.27%49.32M

-19.09%65.12M

-63.44%38.33M

-76.39%26.3M

Current changes in cash

125.40%894K

100.03%11K

-184.66%-44.99M

-153.14%-5.84M

-129.63%-3.56M

13.77%-3.52M

7.68%-32.07M

-2.87%-15.81M

127.66%10.99M

282.70%12.03M

End cash Position

-61.89%5.23M

-74.85%4.34M

-91.23%4.33M

-73.48%10.17M

-47.80%13.73M

-43.23%17.25M

-24.27%49.32M

-63.44%38.33M

Free cash flow

142.84%1.45M

97.37%-229K

-356.34%-23.08M

-116.44%-4.96M

-134.01%-6.03M

83.69%-3.39M

51.89%-8.7M

106.21%9M

173.44%30.16M

146.15%17.72M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	142.84%1.45M	97.37%-229K	-346.67%-23.1M	-116.47%-4.98M	-134.03%-6.03M	83.63%-3.39M	51.31%-8.7M	116.99%9.37M	-37.00%30.24M	146.35%17.72M
Net income from continuing operations	56.50%-1.05M	64.98%-809K	-816.85%-7.7M	-103.18%-1.54M	90.20%-1.43M	83.77%-2.41M	87.08%-2.31M	101.35%1.07M	-3.38%48.45M	69.15%-14.63M
Depreciation and amortization	39.53%180K	392.59%133K	-25.00%900K	94.62%615K	-52.75%129K	-54.26%129K	-91.79%27K	63.04%1.2M	113.42%316K	-73.50%273K
Other non cash items	1,155.56%190K	410.00%186K	73.32%-107K	-68.09%-632K	6,130.00%603K	-125.00%-18K	-757.14%-60K	-155.69%-401K	92.83%-376K	-100.43%-10K
Change In working capital	150.82%776K	102.17%150K	-326.97%-17.45M	83.64%-3.46M	-120.01%-5.56M	81.73%-1.53M	-189.92%-6.9M	-189.00%-4.09M	-3,367.70%-21.14M	1,849.02%27.79M
-Change in prepaid assets	-68.81%500K	102.34%34K	222.42%2M	1,333.63%3.24M	-114.79%-1.39M	115.93%1.6M	-238.12%-1.45M	155.11%620K	-86.75%226K	394.31%9.41M
-Change in payables and accrued expense	98.92%-40K	93.04%-301K	-684.99%-17.85M	68.11%-4.46M	-128.79%-5.37M	-301.53%-3.69M	-25.93%-4.32M	-14.71%3.05M	-65.61%-14M	233.50%18.65M
-Change in other current assets	30.64%631K	3,410.53%629K	85.25%-1.13M	69.74%-2.31M	--721K	--483K	---19K	---7.64M	---7.64M	--0
-Change in other current liabilities	-488.89%-315K	80.83%-212K	-289.26%-471K	-71.21%76K	283.85%478K	164.80%81K	---1.11M	-105.66%-121K	-80.88%264K	-165.00%-260K
Cash from discontinued investing activities
Operating cash flow	142.84%1.45M	97.37%-229K	-346.62%-23.08M	-116.40%-4.96M	-134.03%-6.03M	83.63%-3.39M	51.31%-8.7M	106.56%9.36M	176.43%30.24M	146.35%17.72M
Investing cash flow
Cash flow from continuing investing activities			0	0				84.03%-355K	95.11%-74K	103.85%7K
Net PPE purchase and sale	----	----	----	----	----	----	----	----	----	--0
Net intangibles purchase and sale	----	----	--0	--0	----	----	----	83.78%-355K	93.73%-95K	102.78%7K
Cash from discontinued investing activities
Investing cash flow	----	----	--0	--0	----	----	----	84.03%-355K	95.11%-74K	103.85%7K
Financing cash flow
Cash flow from continuing financing activities			101.34%3.15M	101.79%2M	-100.06%-1K			-281.55%-235.21M	-8,373.84%-111.95M	-94.54%1.74M
Net issuance payments of debt	----	----	--0	--0	----	----	----	-338.86%-219.43M	---94.43M	--0
Net common stock issuance	----	----	27.67%3.15M	14,200.00%2M	-100.04%-1K	----	----	-98.66%2.47M	-98.95%14K	-92.32%2.45M
Net preferred stock issuance	----	----	--0	----	----	----	----	---16.97M	----	----
Net other financing activities	----	----	----	----	----	----	----	75.21%-1.27M	---540K	----
Cash from discontinued financing activities
Financing cash flow	----	----	101.34%3.15M	101.79%2M	-100.06%-1K	----	----	-281.55%-235.21M	-8,373.84%-111.95M	-94.54%1.74M
Net cash flow
Beginning cash position	-74.85%4.34M	-91.23%4.33M	-24.27%49.32M	-73.48%10.17M	-47.80%13.73M	-43.23%17.25M	-24.27%49.32M	-19.09%65.12M	-63.44%38.33M	-76.39%26.3M
Current changes in cash	125.40%894K	100.03%11K	-184.66%-44.99M	-153.14%-5.84M	-129.63%-3.56M	13.77%-3.52M	7.68%-32.07M	-2.87%-15.81M	127.66%10.99M	282.70%12.03M
End cash Position	-61.89%5.23M	-74.85%4.34M	-91.23%4.33M	-91.23%4.33M	-73.48%10.17M	-47.80%13.73M	-43.23%17.25M	-24.27%49.32M	-24.27%49.32M	-63.44%38.33M
Free cash flow	142.84%1.45M	97.37%-229K	-356.34%-23.08M	-116.44%-4.96M	-134.01%-6.03M	83.69%-3.39M	51.89%-8.7M	106.21%9M	173.44%30.16M	146.15%17.72M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data